InMed Pharmaceuticals (INM) Short term Debt (2021 - 2022)
InMed Pharmaceuticals (INM) posted Short term Debt of $29312.0 for Q1 2022, down 50.0% on a QoQ basis from $58624.0 in Q4 2021.
Powered by 
Analysis
InMed Pharmaceuticals (INM) Short term Debt (2021 - 2022) Analysis & Trends
InMed Pharmaceuticals has reported Short term Debt for 2 years, with the latest figure at $29312.0 in Q1 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Corning | 145.15 Bn | 142.65 Bn | 1.63 Bn |
| 2 | Ati | 28.33 Bn | 27.54 Bn | 309.80 Mn |
| 3 | Qnity Electronics | 26.46 Bn | 25.50 Bn | 666.00 Mn |
| 4 | International Flavors & Fragrances | 21.61 Bn | 21.04 Bn | 853.00 Mn |
| 5 | DuPont de Nemours | 17.56 Bn | 15.82 Bn | 639.00 Mn |
| 6 | Avery Dennison | 13.06 Bn | 12.83 Bn | 729.40 Mn |
| 7 | Solstice Advanced Materials | 10.13 Bn | 9.38 Bn | 370.00 Mn |
| 8 | Element Solutions | 8.78 Bn | 8.59 Bn | 334.00 Mn |
| 9 | Eastman Chemical | 7.87 Bn | 7.18 Bn | 560.00 Mn |
| 10 | InMed Pharmaceuticals | 5.30 Mn | 61,528.56 | - |